NCT05666505

Brief Summary

Children in rural and underserved communities experience a disproportionately high burden of infection-related hearing loss, which is often preventable with timely identification and follow-up care. A tympanometer is a device that evaluates the health of the middle ear but is often not used in screening programs due to barriers of high cost and need for trained professionals such as audiologists to use the device. To address these barriers, a low cost, lay friendly, mobile health (mHealth) prototype tympanometer has been developed. In addition, a machine learning (ML) algorithm has been designed to guide lay users to interpret tympanometer results, overcoming the need for audiologists. Broad implementation of the lay friendly tympanometer and ML algorithm will transform screening in areas where prevalence of infection-related hearing loss is high, and access to specialty care is limited. In this study the prototype mHealth tympanometer will be evaluated against commercial tympanometry. It will be used by audiologists, an essential step before testing the performance of the device with lay users. Approximately 20 adult patients and 10 pediatric patients with various middle ear pathologies will be enrolled in the study, with the goal of obtaining 60 ears with data from both the prototype and commercial tympanometers. Audiologists will obtain tympanometry measurements on both ears of each participant and interpret the results, first with the prototype device and then with the commercial tympanometer that is typically used during a clinical evaluation. Tympanometry interpretation will include classification into one of 3 categories (Type A, B, or C). Agreement in results between the prototype and commercial devices will be assessed. Agreement between audiologist interpretations and the ML algorithm from the prototype mHealth tympanometer will be assessed.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 27, 2022

Completed
1.8 years until next milestone

Study Start

First participant enrolled

October 30, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2024

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

January 13, 2026

Completed
Last Updated

January 13, 2026

Status Verified

January 1, 2026

Enrollment Period

1 month

First QC Date

December 13, 2022

Results QC Date

December 5, 2025

Last Update Submit

January 12, 2026

Conditions

Keywords

RuralScreeningTympanometerMobile health (mHealth)Otitis mediaML Algorithm

Outcome Measures

Primary Outcomes (2)

  • Classification Agreement Between Prototype mHealth Tympanometer and Commercial Tympanometer

    Audiologist will test each ear of the participant first with the prototype device, interpret the results into one of the three tympanogram categories (Type A/B/C) and record the results. The procedure will be repeated with a commercial device. Agreement between the two devices with respect to the classification categories will be assessed.

    Same day as participant visit, up to 10 minutes

  • Classification Agreement Between Audiologist and ML Algorithm Interpretations Using Prototype mHealth Tympanometer

    Tympanogram results collected using the prototype mHealth tympanometer will be run through the ML algorithm for classification into Type A/B/C. Agreement between the audiologist and the ML algorithm with respect to the classification categories will be assessed.

    Same day as participant visit, up to 10 minutes

Study Arms (1)

Tympanometer Comparison

EXPERIMENTAL

Both ears of each participant will be tested first with the prototype mHealth tympanometer followed by standard of care commercial tympanometer

Device: Prototype mHealth tympanometerDevice: Standard of care commercial tympanometer

Interventions

The prototype mHealth tympanometer functions similarly to a commercial tympanometer. Tympanometers are designed to assess middle ear function by measuring changes in acoustic tone related to subtle movement of the tympanic membrane from an applied air pressure sweep. An audiologist will review the tympanogram tracings and classify results as Type A, B, or C.

Tympanometer Comparison

A commercial tympanometer routinely used as part of standard of care will be used as the comparison. Tympanometers are designed to assess middle ear function by measuring changes in acoustic tone related to subtle movement of the tympanic membrane from an applied air pressure sweep. An audiologist will review the tympanogram tracings and classify results as Type A, B, or C.

Tympanometer Comparison

Eligibility Criteria

Age1 Year+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Presenting to Audiology Clinic for evaluation, where tympanometry is warranted for testing at the discretion of the audiologist
  • Presence of various middle ear health states/pathologies that result in Type A, B, C tympanograms
  • English-speaking

You may not qualify if:

  • Children or adults with cognitive disabilities
  • Unable to provide consent/assent
  • Individuals who are unable to sit still
  • Any other condition that in the opinion of the investigator, might interfere with the safe conduct of the study or place the participant at increased risk

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hearing LossOtitis Media

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOtitis

Results Point of Contact

Title
Samantha Kleindienst Robler, AuD, PhD
Organization
University of Arkansas for Medical Sciences

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Model Details: Each participant will be first tested with prototype mHealth tympanometer, and then with a commercial tympanometer routinely used in clinical settings.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2022

First Posted

December 27, 2022

Study Start

October 30, 2024

Primary Completion

December 10, 2024

Study Completion

December 10, 2024

Last Updated

January 13, 2026

Results First Posted

January 13, 2026

Record last verified: 2026-01